ClinicalTrials.Veeva

Find clinical trials for Acute Myeloid Leukemia (AML) in Salt Lake City, UT

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Acute Myeloid Leukemia
Leukemia
Myeloid Leukemia
Myelodysplastic Syndromes
Preleukemia
Syndrome
Cancer

Acute Myeloid Leukemia (AML) trials near Salt Lake City, UT, USA:

JSP191 Antibody Conditioning Regimen in MDS/AML Subjects Undergoing Allogenic Hematopoietic Stem Cell Transplantation

and fludarabine, in subjects with Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML) undergoing allog...

Enrolling
ACUTE MYELOID LEUKEMIA; AML
MYELODYSPLASTIC SYNDROME; MDS
Biological: Humanized anti-CD117 Monoclonal Antibody (JSP191)

Phase 1

Jasper Therapeutics

Salt Lake City, Utah, United States and 5 other locations

to venetoclax + azacitidine in adults recently diagnosed with AML who are unable to be treated with intensive chemotherapy.Participants will...

Active, not recruiting
Acute Myeloid Leukemia (AML)
Drug: Venetoclax
Drug: Pevonedistat

Phase 2

Takeda
Takeda

Salt Lake City, Utah, United States and 56 other locations

This trial will seek to extend the preliminary findings of efficacy of MBG453 in combination with hypomethylating agents (HMA) by evaluating MBG453 i...

Active, not recruiting
Acute Myeloid Leukemia
Drug: Venetoclax
Drug: MBG453

Phase 2

Novartis
Novartis

Salt Lake City, Utah, United States and 27 other locations

[GO]) improves survival of children/adolescents/young adults with acute myeloid leukemia (AML) in 1st relapse who...

Enrolling
Acute Myeloid Leukemia
Drug: Fludarabine
Drug: Cytarabine

Phase 3

LLS PedAL Initiative, LLC

Salt Lake City, Utah, United States and 71 other locations

This is a clinical study for adult patients who have recently been diagnosed with acute myeloid leukemia or AML. ...

Active, not recruiting
Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) Mutation
Acute Myeloid Leukemia (AML)
Drug: gilteritinib
Drug: azacitidine

Phase 3

Astellas
Astellas

Salt Lake City, Utah, United States and 110 other locations

Eligible untreated patients with FLT3 acute myeloid leukemia (AML) between the ages of 18 and 70 will be randomiz...

Active, not recruiting
Acute Myeloid Leukemia
Drug: Gilteritinib
Drug: Daunorubicin

Phase 2

PrECOG

Salt Lake City, Utah, United States and 43 other locations

three separate safety run-in cohorts in neuroblastoma, acute myeloid leukemia (AML), and acute lymphobla...

Active, not recruiting
Acute Lymphoblastic Leukemia (ALL)
Acute Myeloid Leukemia (AML)
Drug: Fludarabine
Drug: Idasanutlin

Phase 1, Phase 2

Roche
Roche

Salt Lake City, Utah, United States and 19 other locations

Locations recently updated

T cell therapy (VCAR33) in patients with relapsed or refractory Acute Myeloid Leukemia (AML) after human leukocyt...

Enrolling
Leukemia, Myeloid, Acute
Biological: VCAR33

Phase 1, Phase 2

Vor Biopharma

Salt Lake City, Utah, United States and 11 other locations

(mCRPC), higher risk myelodysplastic syndrome (HRMDS), acute myeloid leukemia (AML) and newly diagnosed intermed...

Active, not recruiting
Acute Myeloid Leukemia (AML)
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Drug: ASTX727
Drug: Dexamethasone

Phase 1, Phase 2

Karyopharm Therapeutics
Karyopharm Therapeutics

Salt Lake City, Utah, United States and 45 other locations

Acute Myeloid Leukaemia (AML) is an aggressive and rare cancer of myeloid cells (a white blood cell responsible f...

Active, not recruiting
Acute Myeloid Leukemia (AML)
Drug: Placebo
Drug: Venetoclax

Phase 3

AbbVie
AbbVie

Salt Lake City, Utah, United States and 171 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems